Overdiagnosis concerns raised for CT lung cancer screening
People participating in any future computed tomography lung cancer screening program would face a significant risk for overdiagnosis, US researchers caution in JAMA Internal Medicine. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - January 22, 2014 Category: Cancer & Oncology Source Type: news
Unexpected toxicity of pazopanib/pemetrexed in NSCLC halts study
A phase II study comparing first-line combination pazopanib/pemetrexed chemotherapy with the standard cisplatin/pemetrexed treatment in non-small-cell lung cancer was terminated early owing to an increased frequency of adverse events in the experimental arm. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - December 17, 2013 Category: Cancer & Oncology Source Type: news
Selenium fails to protect NSCLC patients against second primary tumors
Selenium supplementation does not reduce the risk for second primary tumors in patients with resected non–small-cell lung cancer, researchers say. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - December 17, 2013 Category: Cancer & Oncology Source Type: news
Erlotinib ‘dose-to-rash’ strategy effective in advanced NSCLC
Erlotinib as first-line therapy in patients with advanced non-small-cell lung cancer is equivalent to chemotherapy with regard to overall survival, an “all-comers” phase II trial has shown. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - December 16, 2013 Category: Cancer & Oncology Source Type: news
Chest wall resection effective for recurrent mesothelioma
Salvage chest wall resection could lengthen survival in patients with isolated chest wall recurrence of malignant pleural mesothelioma, research indicates. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - December 16, 2013 Category: Cancer & Oncology Source Type: news
Cetuximab fails in second-line combination for recurrent NSCLC
Results from a phase III trial indicate that cetuximab should not be given alongside chemotherapy in patients with recurrent non-small-cell lung cancer after platinum-based therapy. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - December 13, 2013 Category: Cancer & Oncology Source Type: news
Pemetrexed, paclitaxel regimens equally effective in NSCLC
PointBreak trial results suggest that pemetrexed- and paclitaxel-based chemotherapy offer comparable survival outcomes and tolerability for patients with advanced nonsquamous non-small-cell lung cancer (NSCLC) but with differing toxicity profiles. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - December 10, 2013 Category: Cancer & Oncology Source Type: news
Novel multi-kinase inhibitor shows early promise in NSCLC
Researchers have reported promising early data on an investigational drug that targets two tyrosine kinase receptors that drive invasive growth and drug resistance in non-small-cell lung cancer. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - December 9, 2013 Category: Cancer & Oncology Source Type: news
Training advised to plug lung cancer care gaps
Guideline-consistent care for patients with suspected lung cancer with mediastinal lymphadenopathy without distant metastases varies by region and physician characteristics, say researchers. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - December 5, 2013 Category: Cancer & Oncology Source Type: news
Lung cancer is costliest cancer in European Union
The total cost of cancer care across the European Union was an estimated € 126 billion in 2009, with lung cancer having the highest cost, at 15% of the total. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - December 4, 2013 Category: Cancer & Oncology Source Type: news
Investigational c-Met inhibitor shows early promise in NSCLC
A first-in-class drug that inhibits c-Met, a receptor tyrosine kinase, has demonstrated good tolerability when combined with erlotinib in the treatment of Japanese patients with advanced/metastatic non-small-cell lung cancer. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - December 3, 2013 Category: Cancer & Oncology Source Type: news
Clinicians ‘nihilistic’ toward lung cancer patients
Clinicians tend to view their lung cancer patients more negatively than patients with other solid tumors, study findings indicate. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - December 3, 2013 Category: Cancer & Oncology Source Type: news
Four-drug regimen shows first-line efficacy in advanced NSCLC
A four-drug combination of cetuximab, bevacizumab, carboplatin, and paclitaxel is effective and has acceptable safety as a first-line treatment for advanced non-small-cell lung cancer, US researchers report. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - December 2, 2013 Category: Cancer & Oncology Source Type: news
Endobronchial ultrasound has edge for lung cancer staging
Endobronchial ultrasound-guided transbronchial needle aspiration is a better primary procedure than endoscopic ultrasound-guided fine needle aspiration for staging non-small-cell lung cancer, study results suggest. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - December 1, 2013 Category: Cancer & Oncology Source Type: news
Pneumococcal pneumonia linked to lung cancer risk
Pneumococcal pneumonia is significantly associated with risk for lung cancer, show findings from a national study in Taiwan. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - November 13, 2013 Category: Cancer & Oncology Source Type: news
